White matter lesion progression in LADIS: Frequency, clinical effects, and sample size calculations

Stroke

Volumn 43, Issue 10, 2012, Pages 2643-2647

  Schmidt, Reinhold ^a   Berghold, Andrea ^a   Jokinen, Hanna ^b   Gouw, Alida A ^c   Van Der Flier, Wiesje M ^c   Barkhof, Frederik ^d   Scheltens, Philip ^c   Petrovic, Katja ^a   Madureira, Sofia ^e   Verdelho, Ana ^e   Ferro, Jose M ^e   Waldemar, Gunhild ^f,g   Wallin, Anders ^h   Wahlund, Lars Olof ⁱ   Poggesi, Anna ^j   Pantoni, Leonardo ^j   Inzitari, Domenico ^j   Fazekas, Franz ^a   Erkinjuntti, Timo ^b  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c Alzheimer Center   (Netherlands)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^e Centro de Estudos Egas Moniz   (Portugal)

^f University of Copenhagen   (Denmark)

^g HVIDOVRE HOSPITAL   (Denmark)

^h UNIVERSITY OF GOTHENBURG   (Sweden)

ⁱ KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^j UNIVERSITY OF FLORENCE   (Italy)

more..

Author keywords

clinical trials; leukoaraiosis; magnetic resonance imaging; vascular dementia; white matter disease

Indexed keywords

ADULT; AGED; ARTICLE; CALCULATION; CLINICAL ASSESSMENT; COGNITIVE DEFECT; CONTROLLED STUDY; DISABILITY; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; LEUKOARAIOSIS; MAJOR CLINICAL STUDY; MALE; MULTIINFARCT DEMENTIA; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RATING SCALE; VASCULAR DEMENTIA ASSESSMENT SCALE GLOBAL SCORE; WHITE MATTER LESION;

AGED; AGED, 80 AND OVER; COGNITION DISORDERS; DISABILITY EVALUATION; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEUKOARAIOSIS; LEUKOENCEPHALOPATHIES; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; OUTCOME ASSESSMENT (HEALTH CARE); PREVALENCE; PROGNOSIS; SAMPLE SIZE;

EID: 84866743847     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.112.662593     Document Type: Article

References (27)

1. Schmidt R, Fazekas F, Kapeller P, Schmidt H, Hartung HP. MRI white matter hyperintensities: three-year follow-up of the Austrian Stroke Prevention Study. Neurology. 1999;53:132-139. (Pubitemid 29329661)
2. Longstreth WJ Jr., Arnold AM, Beauchamp NJ Jr., Manolio TA, Lefkowitz D, Jungreis C, et al. Incidence, manifestations, and predictors of worsening white matter on serial cranial magnetic resonance imaging in the elderly: The Cardiovascular Health Study. Stroke. 2005;36:56-61. (Pubitemid 40054175)
3. Taylor W, MacFall J, Provenzale J, Payne M, McQuoid D, Steffens D, et al. Serial MR imaging of volumes of hyperintense white-matter-lesions in elderly patients: correlation with vascular risk factors. Am J Roentgenol. 2003;181:571-576. (Pubitemid 36909511)
4. Sachdev P, Wen W, Chen X, Brodaty H. Progression of white matter hyperintensities in elderly individuals over 3 years. Neurology. 2007;68: 214-222. (Pubitemid 46105740)
5. Garde E, Lykke Mortensen E, Rostrup E, Paulson OB. Decline in intelligence is associated with progression in white matter hyperintensity volume. J Neurol Neurosurg Psychiatry. 2005;76:1289-1291. (Pubitemid 41208387)
6. Wahlund L, Almkvist O, Basin H, Julin P. MRI in successful ageing, a 5-year follow-up study from eighth to ninth decade of life. Magn Res Imag. 1996;14:601-608. (Pubitemid 26347285)
7. Veldink JH, Scheltens P, Jonker C, Launer LJ. Progression of cerebral white matter hyperintensities on MRI is related to diastolic blood pressure. Neurology. 1998;51:319-320. (Pubitemid 28345419)
8. Whitman GT, Tang Y, Lin A, Baloh RW, Tang T. A prospective study of cerebral white-matter abnormalities in older people with gait dysfunction. Neurology. 2001;57:990-994. (Pubitemid 32880191)
9. Schmidt R, Enzinger C, Ropele S, Schmidt H, Fazekas F, Austrian Stroke Prevention Study. Progression of cerebral white matter lesions: 6-year results of the Austrian Stroke Prevention study. Lancet. 2003;361: 2046-2048. (Pubitemid 36695049)
10. van Dijk EJ, Prins ND, Vermeer SE, Vrooman HA, Hofman A, Koudstaal PJ, et al. C-reactive protein and cerebral small vessel disease: The Rotterdam Scan Study. Circulation. 2005;112:900-905. (Pubitemid 41170078)
11. ten Dam VH, van den Heuvel DM, van Buchem MA, Westendorp RG, Bollen EL, Ford I, et al. PROSPER Study Group. Effect of pravastatin on cerebral infarcts and white matter lesions. Neurology. 2005;64: 1807-1809. (Pubitemid 40695828)
12. Schmidt R, Ropele S, Enzinger C, Petrovic K, Smith S, Schmidt H, et al. White matter lesion progression, brain atrophy, and cognitive decline: the Austrian Stroke Prevention study. Ann Neurol. 2005;58:610-616. (Pubitemid 41377225)
13. van den Heuvel DM, ten Dam VH, de Craen AJ, Admiraal-Behloul F, Olofsen H, Bollen EL, et al. Increase in periventricular white matter hyperintensities parallels decline in mental processing speed in a nondemented elderly population. J Neurol Neurosurg Psychiatry. 2006;77: 149-153. (Pubitemid 43220832)
14. Schmidt R, Scheltens P, Erkinjuntti T, Pantoni L, Markus HS, Wallin A, et al. White matter lesion progression: a surrogate endpoint for trials in cerebral small-vessel disease. Neurology. 2004;63:139-144. (Pubitemid 38943791)
15. van Dijk EJ, Prins ND, Vrooman HA, Hofman A, Koudstaal PJ, Breteler MM. Progression of cerebral small vessel disease in relation to risk factors and cognitive consequences: Rotterdam Scan Study. Stroke. 2008; 39:2712-2719.
16. Gouw AA, van der Flier WM, van Straaten EC, Pantoni L, Bastos-Leite AJ, Inzitari D, et al. Reliability and sensitivity of visual scales versus volumetry for evaluating white matter hyperintensity progression. Cerebrovasc Dis. 2008;25:247-253. (Pubitemid 351450428)
17. Prins ND, van Straaten EC, van Dijk EJ, Simoni M, van Schijndel RA, Vrooman HA, et al. Measuring progression of cerebral white matter lesions on MRI: visual rating and volumetrics. Neurology. 2004; 621533-1539.
18. Gouw AA, van der Flier WM, Fazekas F, van Straaten EC, Pantoni L, Poggesi A, et al. Progression of white matter hyperintensities and incidence of new lacunes over a 3-year period: the Leukoaraiosis and Disability study. Stroke. 2008;39:1414-1420.
19. Pantoni L, Basile AM, Pracucci G, Asplund K, Bogousslavsky J, Chabriat H, et al. Impact of Age-Related Cerebral White Matter Changes on the Transition to Disability-The LADIS study: rationale, design and methodology. Neuroepidemiology. 2005;24:51-62. (Pubitemid 39664108)
20. Madureira S, Verdelho A, Ferro J, Basile AM, Chabriat H, Erkinjuntti T, et al. Development of a neuropsychological battery for the Leukoaraiosis and Disability in the Elderly Study (LADIS): experience and baseline data. Neuroepidemiology. 2006;27:101-116. (Pubitemid 44387445)
21. Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol. 1987;149:351-356. (Pubitemid 17104996)
22. Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969;9: 179-186.
23. Ferris SH. General measures of cognition. Int Psychogeriatr. 2003;15: 215-217. (Pubitemid 37175193)
24. Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer's disease. Am J Psychiatry. 1984;141:1356-1364.
25. Hachinski V, Iadecola C, Petersen RC, Breteler MM, Nyenhuis DL, Black SE, et al. National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke. 2006;37:2220-2241. (Pubitemid 44337162)
26. Ylikoski R, Jokinen H, Andersen P, Salonen O, Madureira S, Ferro J, et al. Comparison of the Alzheimer's Disease Assessment Scale Cognitive Subscale and the Vascular Dementia Assessment Scale in differentiating elderly individuals with different degrees of white matter changes. The LADIS Study. Dement Geriatr Cogn Disord. 2007;24:73-81. (Pubitemid 47094064)
27. Schmidt R, Petrovic K, Ropele S, Enzinger C, Fazekas F. Progression of leukoaraiosis and cognition. Stroke. 2007;38:2619-2625. (Pubitemid 47329648)